Drakes Landing Associates, L.P. v. Tilden Park Capital Management, L.P.
CourtCourt of Chancery of Delaware
Date FiledJuly 29, 2026
DocketC.A. No. 2025-0898-NAC
StatusPublished
📰 News Coverage: Read the LAWS.com news report on this case
Full Opinion
IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE
DRAKES LANDING ASSOCIATES,
L.P., MICHAEL DAVIS,
EDUCATIONAL TESTING SERVICE,
POTENCIA VENTURES, ZEPHYR
PEACOCK INDIA FUND III LIMITED,
ZEPHYR MANT RA LLC, ZEPHYR
PEACOCK INDIA III FUND, Ai8
VENTURES FUND II, L.P., KNOTT
PARTNERS, LP, KLAAS ELSINGA,
UNIPLAN CONSULTING, LLC,
Plaintiffs,
v. C.A. No. 2025-0898-NAC
TILDEN PARK CAPITAL
MANAGEMENT, L.P., a Delaware
limited partnership, KING STREET
CAPITAL, L.P. a Delaware limited
partnership, ROBERT PARTLOW,
PHILLIP RIESE, MANOLO
SANCHEZ, and MPOWER
FINANCING, PBC, a Delaware
corporation,
Defendants.
OPINION
Date Submitted: April 27, 2026
Date Decided: July 29, 2026
David A. Jenkins, Jason Z. Miller, SMITH, KATZENSTEIN & JENKINS LLP;
Attorneys for Plaintiff.
Sarah R. Martin, Bryan T. Reed, GREENBERG TRAURIG, LLP, Wilmington,
Delaware; Counsel for Defendant MPower Financing, PBC.
Brian C. Ralston, Ryan M. Ellingson, POTTER ANDERSON & CORROON,
Wilmington, Delaware; Counsel for Defendants Robert Partlow, Phillip Riese, and
Manolo Sanchez.
Martin S. Lessner, Jason W. Rigby, YOUNG CONAWAY STARGATT & TAYLOR,
LLP, Wilmington, Delaware; Michael C. Keats, FRIED, FRANK, HARRIS, SHRIVER
& JACOBSON LLP, New York, New York; Katherine L. St. Romain, FRIED, FRANK,
HARRIS, SHRIVER & JACOBSON LLP, Washington, DC; Counsel for Defendant
King Street Capital, L.P.
John P. DiTomo, Jialu Zou, MORRIS, NICHOLS, ARSHT & TUNNELL LLP,
Wilmington, Delaware; Richard S. Horvath, Jr., DECHERT LLP, San Francisco,
California; Michael H. McGinley, DECHERT LLP, Philadelphia, Pennsylvania;
Counsel for Defendant Tilden Park Capital Management, L.P.
COOK, V.C.
Two of a public benefit corporation’s lenders proposed a financing transaction
that would provide the company with $20 million in urgently needed financing. As
part of the financing, the debt owed by the company to the two lenders would convert
into equity, increasing the lenders’ stock holdings from around 25% to nearly 85%,
and diluting the other stockholders. The public benefit corporation appointed an
independent and disinterested special committee to evaluate the transaction. The
special committee in turn retained independent legal and financial advisors and
ultimately approved the deal.
This case presents an issue of first impression: how Revlon and its progeny
apply, if at all, to the board of a public benefit corporation navigating a change-of-
control transaction. The answer to that question depends on whether one
understands Revlon as imposing a standard of conduct (obtain the best price
reasonably available) or a standard of review (enhanced scrutiny). Delaware
decisions are less than clear on this issue. Directors of public benefit corporations
are statutorily required to balance stockholders’ pecuniary interests with other
considerations, in tension with Revlon’s singular focus on maximizing price. I
conclude that Revlon does not impose a standard of conduct on public benefit
corporation directors, but that its underlying standard of review—enhanced scrutiny,
which I will call “PBC” enhanced scrutiny—may still apply. I need not decide,
however, whether that standard governs the outcome here because Plaintiffs have
failed to plead facts sufficient to rebut the statutory safe harbor in Section 365(b) of
the Delaware General Corporation Law (“DGCL”).
Plaintiffs, current and former stockholders of the public benefit corporation,
brought this action against the special committee for breach of fiduciary duty and
against the two lenders for aiding and abetting that breach. Because the safe harbor
protects the special committee’s decision, both claims must be dismissed. Defendants’
motion to dismiss is granted, and the Complaint is dismissed with prejudice.
I. FACTUAL BACKGROUND
The facts are drawn from the Verified Complaint for Injunctive Relief
(“Complaint”). 1 At this procedural stage, the Court credits the Complaint’s well-pled
allegations and draws all reasonable inferences in Plaintiffs’ favor. The Court also
considers documents incorporated by reference in the Complaint.
A. MPower Faces a Need for Short-Term Financing
MPower Financing, PBC (“MPower” or the “Company”) is a Delaware public
benefit corporation described as “the leader for international student financing in
North America.” 2 The Company’s mission is to provide international students with
the opportunity to attend postsecondary education in the United States. 3 To finance
these endeavors, MPower raises funds from banks and other lenders. 4 Since its
1 Citations in the form “Compl. ¶ ___” refer to paragraphs of the Verified Complaint
for Injunctive Relief, which is the operative pleading. Dkt. 1. Citations in the form “Defs.
OB Ex. ___ at ___” refer to exhibits Defendants filed in support of their Motion to Dismiss.
Dkt. 31.
2 Compl. ¶ 3.
3 Id.
4 Id.
2
inception, the Company has issued more than $600 million in loans to qualified
international students. 5
In late 2024, the Company appeared to be on the way to profitability. Gross
revenues had increased, along with the number of loan approvals from potential
financiers. 6 But at the beginning of 2025, the Company found itself in a short-term
financial pinch. Under its existing debt covenants, MPower was required to have a
minimum cash balance of $17 million by January 31, 2025. 7 The Company had
previously sought to raise equity capital toward the end of 2025 to meet this
requirement, but these efforts proved unfruitful. 8
B. The Proposed Term Sheet from Tilden Park and King Street
On January 20, 2025, in response to MPower’s urgent need for capital,
Defendants Tilden Park Management, L.P. (“Tilden Park”) and King Street Capital,
L.P. (“King Street,” and, together with Tilden Park, the “Funds”) jointly sent a
proposed term sheet to the Company, which offered $15 million in immediate
financing. 9 On January 25, 2025, MPower’s CEO, Manu Smadja, responded to the
Funds’ term sheet with minor comments. 10
5 Id.
6 Id. ¶ 6.
7 Id. ¶ 8.
8 Id. ¶ 7. In October 2024, the Company appointed Compass Point, an investment
bank, to raise up to $100 million in equity capital at more than $20 per share. Id.
9 Id. ¶ 9.
10 Id.
3
The Funds were no strangers to MPower. Both were major lenders to the
Company, collectively holding nearly $109 million of MPower’s debt. 11 The Funds
also owned 25.5% of the Company’s common stock, in aggregate. 12 Tilden Park had
two designees on the MPower board of directors (“Board”): Samuel Alcoff and
Christopher Gamatoni. 13
On January 30, just one day before the compliance deadline for the debt
covenants, the Funds presented a modified term sheet to the Company. 14 The new
term sheet raised the amount of financing to $20 million, and included a conversion
option through which the Funds could convert into equity the nearly $109 million of
debt owed to the Funds at $2.04 per share. 15 Upon conversion of the debt into equity,
the Funds would collectively own nearly 85% of the Company’s stock. 16 The
conversion price also represented a significant discount when compared to MPower’s
most recent financing round from nearly four years earlier in July 2021—which
valued the Company’s stock price at $15.50 per share. 17
11 Id. ¶ 5.
12 Id.
13 Id. King Street did not have any board designees during the relevant time period.
14 Id. ¶ 10.
15 Id. The final term sheet ultimately increased the conversion price to $2.25 per
share.
16 Id.
17 Id.
4
On January 31, the Board convened and approved the term sheet on a non-
exclusive basis. 18 The Tilden Park designees recused themselves from the vote. 19
During that meeting, one director, Phillip Reise, opined that any dilutive transaction
should be subject to stockholder approval. 20
C. MPower’s Board Forms a Special Committee
In February 2025, the Board resolved to appoint a three-person special
committee to consider the Funds’ term sheet. 21 The committee consisted of
Defendants Robert Partlow, Phillip Reise, and Manolo Sanchez (the “Special
Committee”). 22 All three members of the Special Committee were disinterested
directors on the MPower Board. 23 An attorney from the Company’s counsel at
Greenberg Traurig recommended that the Board obtain stockholder approval of the
proposed transaction. 24 CEO Manu Smadja concurred. 25 But not all were in
18 Id. ¶ 11.
19 Id.
20 Id.
21 Id. ¶ 12.
22 Id.
23 Plaintiffsconcede that the Special Committee members were disinterested and
independent directors. See Dkt. 30, Transcript of 8/21/2025 Telephonic Oral Argument and
Ruling of the Court on Plaintiffs’ Motion for Expedited Proceedings (“MTE Transcript”), at
34; Dkt. 45, Transcript of Oral Argument on Defendants’ Motion to Dismiss Held Via Zoom
(“MTD Transcript”) at 48:9–23.
24 Compl. ¶ 12.
25 Id.
5
agreement. Samuel Alcoff, a Tilden Park designee, objected to a stockholder vote and
recommended that the Special Committee hire its own legal counsel. 26
The Special Committee hired Potter Anderson & Corroon LLP as its counsel
and Gordian Capital (“Gordian”) as its financial advisor. 27 The Complaint does not
allege that either advisor was interested in the Financing Transaction or beholden to
the Funds or Tilden Park’s Board designees. The Special Committee instructed
Gordian “to search for deals for the Company that raised capital in an amount
equivalent to Tilden Park’s and King Street’s proposal, but with much less dilution
to the other stockholders.” 28 On March 6, the Special Committee opened a data room
to interested third parties, with term sheets due by March 15. 29 It is unclear from
the record how many offers were submitted during the pendency of the bidding
process. Plaintiffs claim that Gordian “did not do a thorough job,” including by failing
to approach strategic investors such as Sallie Mae, Navient, Sofi, or Prodigy. 30
During the bidding process, a group of existing MPower stockholders
approached Gordian with an offer to raise $20 million in financing as an alternative
26 Id. ¶ 13.
27 Id.
28 Id. ¶ 14.
29 Id.
30 Id.
6
to the Funds’ term sheet. 31 The Complaint does not provide any details about this
offer or its material terms. 32 Gordian rejected the stockholder group’s advance. 33
On March 17 and 20, two groups of stockholders—collectively owning more
than 50% of MPower stock—sent letters to the Board objecting to the proposed
transaction and requesting that the matter be put to a stockholder vote. 34 No
stockholder vote was ever held, and the Special Committee approved the proposed
transaction on March 28. 35
D. The Financing Transaction Goes Forward
On March 28, 2025, following Special Committee approval, the MPower Board
entered into an Exchange Agreement with the Funds through which the Funds would
lend the Company $28,125,000 through a secured promissory note (the “Financing
Transaction”). 36 The same day, the Funds also entered into a Governance Agreement
31 Id. ¶ 18.
32 In their answering brief, Plaintiffs argue that the stockholder group’s alternative
offer was “on terms that would not entail the same dilutive effects as the Transaction.” Pls.
AB at 10. Plaintiffs cite to paragraph 18 of the Complaint in support, which says nothing
about the terms of the alternative proposal or its dilutive effects. Compl. ¶ 18 (“A group of
existing MPower stockholders approached Gordian with an offer to raise $20 million, but
Gordian rebuffed that effort.”). Plaintiffs cannot supplement their Complaint through their
answering brief. See MCG Cap. Corp. v. Maginn, 2010 WL 1782271, at *5 (Del. Ch. May 4,
2010) (explaining that a plaintiff “is bound to the factual allegations contained in its
complaint” and “cannot supplement the complaint through its brief”); Parseghian ex rel.
Gregory J. Parseghian Revocable Tr. v. Frequency Therapeutics, Inc., 2022 WL 2208899, at
*11 n.82 (Del. Ch. June 21, 2022) (“Delaware law does not permit plaintiffs to amend their
complaint through briefing.”). And Plaintiffs’ argument that the terms were less dilutive is
conclusory.
33 Compl. ¶ 18.
34 Id. ¶ 22.
35 Id. ¶ 23.
36 Id.; Defs. OB Exs. 4, 5.
7
with the Company. 37 Under the Governance Agreement’s provisions, Tilden Park is
entitled to appoint four directors, and King Street is entitled to appoint three
directors to the Board. 38 The Governance Agreement also requires written consent
from both Tilden Park and King Street before MPower may (i) issue additional stock,
(ii) incur additional debt, (iii) enter into a merger or recapitalization, (iv) change
corporate documents; (v) change board size; (vi) hire or fire management employees;
or (vii) commence a bankruptcy proceeding. 39
Plaintiffs’ chief grievance with the Financing Transaction, however, is the
significant dilution of existing stockholder equity. Upon completion of the Financing
Transaction, the Funds would collectively own approximately 85% of MPower stock. 40
E. Procedural History
Plaintiffs Drakes Landing Associates, L.P., Michael Davis, Educational
Testing Service, Potencia Ventures, Zephyr Peacock India Fund III Limited, Zephyr
Mantra LLC, Zephyr Peacock India III Fund, Ai8 Ventures Fund II, L.P., Knott
Partners, LP, Klaas Elsinga, and UniPlan Consulting LLC are holders of MPower
37 Compl. ¶ 20.
38 Id.
39 Id.
40 Id. ¶ 19.Pursuant to the Exchange Agreement, the conversion date for the swap is
triggered on the earlier of (i) December 31, 2025 or (ii) the date on which MPower raises $25
million through the issuance of stock. See id. ¶ 20; Def. OB Ex. 5 at 13. The record is unclear
as to whether the conversion occurred as of the date of this ruling, and the parties have not
represented one way or the other.
8
common stock. 41 In aggregate, Plaintiffs own nearly 30% of the Company’s common
stock, though the Financing Transaction would significantly reduce this figure. 42
Plaintiffs filed the Complaint in this action on August 6, 2025. 43 In the
Complaint, Plaintiffs assert a claim for breach of fiduciary duty against the Special
Committee (Count I), along with a secondary aiding-and-abetting claim against the
Funds (Count II). Plaintiffs also seek injunctive relief against MPower and the
Special Committee members (Count III).
Plaintiffs sought expedition of these proceedings. On August 21, the Court
denied Plaintiffs’ request to expedite. 44
On September 17, the Company, the Funds, and the Special Committee
members (collectively, “Defendants”) jointly moved to dismiss the Complaint under
Court of Chancery Rule 12(b)(6) (“Motion”). 45 The Court heard argument on
Defendants’ Motion on April 27, 2026. 46 During oral argument, Plaintiffs voluntarily
dismissed Count III. 47 Therefore, only Counts I and II remain. The Court concludes
41 Compl. ¶ 2.
42 Id. ¶ 10 (“Upon full conversion of the debt into equity, Tilden Park and King Street
jointly would own 85% of the Company’s stock, and the other stockholders would be diluted
from 74.5% to 15% of the company’s equity.”).
43 Dkt. 1.
44 Dkt. 24.
45 Dkt. 31.
46 Dkt. 44.
47 MTD Transcript at 50:8–16.
9
that Plaintiffs have failed to state a claim on both Counts. Accordingly, the
Complaint is dismissed with prejudice.
II. LEGAL ANALYSIS
“The standards governing a motion to dismiss for failure to state a claim are
well settled: (i) all well-pleaded factual allegations are accepted as true; (ii) even
vague allegations are ‘well-pleaded’ if they give the opposing party notice of the claim;
(iii) the Court must draw all reasonable inferences in favor of the non-moving party;
and (i[v]) dismissal is inappropriate unless the ‘plaintiff would not be entitled to
recover under any reasonably conceivable set of circumstances susceptible of
proof.’” 48
A. Count I: Breach of Fiduciary Duty
“When determining whether corporate fiduciaries have breached their duties,
Delaware corporate law distinguishes between the standard of conduct and the
standard of review.” 49 “The standard of conduct describes what directors are
expected to do and is defined by the content of the duties of loyalty and care. The
standard of review is the test that a court applies when evaluating whether directors
have met the standard of conduct.” 50
48 Savor, Inc. v. FMR Corp., 812 A.2d 894, 896–97 (Del. 2002) (quoting Kofron v. Amoco
Chems. Corp., 441 A.2d 226, 227 (Del. 1982)).
49 Chen v. Howard-Anderson, 87 A.3d 648, 666 (Del. Ch. 2014); In re Trados Inc.
S’holder Litig., 73 A.3d 17, 35 (Del. Ch. 2013) (same).
50 Trados, 73 A.3d at 35–36.
10
1. The Standard of Conduct
“Delaware corporate law starts from the bedrock principle that ‘[t]he business
and affairs of every corporation . . . shall be managed by or under the direction of a
board of directors.’” 51 “When exercising their statutory responsibility, the standard
of conduct requires that directors [of a traditional corporation] seek ‘to promote the
value of the corporation for the benefit of its stockholders.’” 52 Indeed, “[t]he fiduciary
duties owed by directors of a [traditional] Delaware corporation require the directors
to seek to maximize the value of the corporation over the long-term for the benefit of
the stockholders as residual claimants to the value created by the specific firm that
the directors serve.” 53 Importantly, in the traditional corporation context,
“stockholders’ best interest must always, within legal limits, be the end. Other
constituencies may be considered only instrumentally to advance that end.” 54
The standard of conduct for directors of public benefit corporations is slightly
different. Section 365 of the DGCL governs the fiduciary duties of directors of public
benefit corporations. Section 365(a) provides:
The board of directors shall manage the business and affairs of the
public benefit corporation in a manner that balances the pecuniary
interests of the stockholders, the best interests of those materially
51 Id. (quoting 8 Del. C. § 141(a)).
52 Id. (quoting eBay Domestic Hldgs., Inc. v. Newmark, 16 A.3d 1, 34 (Del. Ch. 2010)).
53 McRitchie v. Zuckerberg, 315 A.3d 518, 564 (Del. Ch. 2024).
54 Trados, 73 A.3d at 37 (quoting Leo E. Strine, Jr., Our Continuing Struggle with the
Idea that For–Profit Corporations Seek Profit, 47 WAKE FOREST L. REV. 135, 147 n.34 (2012))
(internal quotation marks omitted).
11
affected by the corporation’s conduct, and the specific public benefit or
public benefits identified in its certificate of incorporation. 55
In other words, while directors of traditional corporations must perform their
fiduciary duties with the sole focus of stockholder wealth maximization, directors of
public benefit corporations must balance stockholder pecuniary interests with the
interests of other stakeholders.
2. The Standard of Review
“Delaware has three tiers of review for evaluating director decision-making:
the business judgment rule, enhanced scrutiny, and entire fairness.” 56 For
transactions involving a change of control, the presumptive standard of review is
enhanced scrutiny under Revlon and its progeny. 57 “Enhanced scrutiny applies in
this setting because ‘the potential sale of a corporation has enormous implications for
corporate managers and advisors, and a range of human motivations, including but
by no means limited to greed, can inspire fiduciaries and their advisors to be less than
faithful.’” 58
55 8 Del. C. § 365(a). See also id. § 362(a) (“[A] public benefit corporation shall be
managed in a manner that balances the stockholders’ pecuniary interests, the best interests
of those materially affected by the corporation's conduct, and the public benefit or public
benefits identified in its certificate of incorporation.”); Leo E. Strine, Jr., Making It Easier for
Directors to “Do the Right Thing”?, 4 HARV. BUS. L. REV. 235, 243 (2014) (“This general
provision [referring to § 362(a)] is matched by a more specific one directed to the duties of
directors [referring to § 365(a)] . . . .”).
56 Reis v. Hazelett Strip-Casting Corp., 28 A.3d 442, 457 (Del. Ch. 2011).
57 Firefighters’ Pension Sys. of City of Kansas City, Missouri Trust v. Presidio, Inc.,
251 A.3d 212, 249 (Del. Ch. 2021); Paramount Commc’ns Inc. v. QVC Network Inc., 637 A.2d
34, 45 (Del. 1994).
58 Presidio, 251 A.3d at 249 (quoting In re El Paso Corp. S’holder Litig., 41 A.3d 432,
439 (Del. Ch. 2012)).
12
“Enhanced scrutiny is Delaware’s intermediate standard of review.” 59 Under
enhanced scrutiny, the Court “examines ‘the reasonableness of the end that directors
chose to pursue, the path that they took to get there, and the fit between the means
and the end.” 60 This “reasonableness standard permits a reviewing court to address
inequitable action even when directors may have subjectively believed that they were
acting properly,” but “does not permit a reviewing court to freely substitute its own
judgment for the directors’ judgment.” 61 “Enhanced scrutiny ‘is not a license for law-
trained courts to second-guess reasonable, but debatable, tactical choices that
directors have made in good faith.’” 62
The parties do not appear to dispute that the Financing Transaction is a
change-of-control transaction that, but for MPower’s status as a public benefit
corporation, would be subject to enhanced scrutiny under Revlon. The parties
disagree, however, on whether and how MPower’s status as a public benefit
corporation affects the application of Revlon.
As explained above, Delaware corporation law distinguishes between the
standard of conduct and the standard of review. Delaware decisions are arguably
59 Young Women’s Christian Assoc. of Rochester and Monroe Cnty. v. Hatteras Funds,
LP (“YWCA”), 356 A.3d 459, 488 (Del. Ch. 2026).
60 Id. at 489; see also In re Dollar Thrifty S’holder Litig., 14 A.3d 573, 595–96 (Del. Ch.
2010) (“[A]t bottom Revlon is a test of reasonableness; directors are generally free to select
the path to value maximization, so long as they choose a reasonable route to get there.”);
QVC, 637 A.2d at 45 (“The courts will apply enhanced scrutiny [in sale of control context] to
ensure the directors have acted reasonably.”).
61 Presidio, 251 A.3d at 250 (quotations and citations omitted).
62 Id. (quoting In re Toys “R” Us, Inc. S’holder Litig., 877 A.2d 975, 1000 (Del. Ch.
2005)).
13
unclear as to whether Revlon imposes a standard of conduct or a standard of review
or both. 63 On the one hand, the Delaware Supreme Court has said that “Revlon
neither creates a new type of fiduciary duty in the sale-of-control context nor alters
the nature of the fiduciary duties that generally apply.” 64 On the other hand, the
Court continues to say that “[t]here is only one Revlon duty—to ‘[get] the best price
for the stockholders at a sale of the company.’” 65
63 See J. Travis Laster, Revlon Is A Standard of Review: Why It’s True and What It
Means, 19 FORDHAM J. CORP. & FIN. L. 5, 25–33 (2013) (explaining the existing confusion in
Delaware decisions applying Revlon as a duty to get the best price as opposed to requiring
enhanced scrutiny review); In re USG Corp. S’holder Litig., 2020 WL 5126671, at *28 (Del.
Aug. 31, 2020) (“Revlon ‘duties’ should not be confused with the Revlon standard of review,
applicable principally outside the damages context, under which directors must act
reasonably.”); see also id. (“Describing the duties of directors in way of a control transaction
as ‘Revlon duties,’ to my mind, is something of a misnomer; the fiduciary duties are loyalty
and care, in any situation[.]”).
64 Malpiede v. Townson, 780 A.2d 1075, 1084 (Del. 2001); see also Lyondell Chem. Co.
v. Ryan, 970 A.2d 235, 243 (Del. 2009) (“[T]here are no legally prescribed steps that directors
must follow to satisfy their Revlon duties.”); QVC, 637 A.2d at 43 (“The directors’ fiduciary
duties in a sale of control context are those which generally attach. In short, ‘the directors
must act in accordance with their fundamental duties of care and loyalty.’”) (citation
omitted); Barkan v. Amsted Indus., Inc., 567 A.2d 1279, 1286 (Del. 1989) (“[T]he basic
teaching of [Revlon and Unocal] is simply that the directors must act in accordance with their
fundamental duties of care and loyalty.”); Mills Acquisition Co. v. Macmillan, Inc., 559 A.2d
1261, 1288 (Del. 1989) (“Beyond [seeking the highest value reasonably attainable for
stockholders], there are no special and distinct ‘Revlon duties.’”); In re Lukens Inc. S’holders
Litig., 757 A.2d 720, 731 (Del. Ch. 1999) (“‘Revlon duties’ refer only to a director’s
performance of his or her duties of care, good faith and loyalty in the unique factual
circumstance of a sale of control over the corporate enterprise.”).
65 Lyondell Chem., 970 A.2d at 242 (quoting Revlon, Inc. v. MacAndrews & Forbes
Holdings, Inc, 506 A.2d 173, 182 (Del. 1986)); see also QVC, 637 A.2d at 43–44 (“The
consequences of a sale of control impose special obligations on the directors of a corporation.
. . . In the sale of control context, the directors must focus on one primary objective—to secure
the transaction offering the best value reasonably available for the stockholders[.]”); Dollar
Thrifty, 14 A.3d at 595 (“Revlon does not require that a board, in determining the value-
maximizing transaction, follow any specific plan or roadmap in meeting its duty to take
reasonable steps to secure—i.e., actually attain—the best immediate value.”).
14
Defendants argue that Revlon is inapplicable because its sole focus on
stockholder wealth maximization is inconsistent with Section 365(a)’s balancing
requirement. 66 Construing Revlon as imposing a standard of conduct—that the board
“get the best price for the stockholders at a sale of the company” 67—I agree. To say
that directors of a public benefit corporation “must perform [their] fiduciary duties in
the service of [the] specific objective” of “maximizing the sale price of the
enterprise,” 68 or that they “must focus on” that “primary objective[,]” 69 would be
inconsistent with the public benefit corporation statute’s requirement that directors
consider and balance other interests against stockholder pecuniary interests. 70 Even
66 Defendants’ Reply Brief in Further Support of Their Motion to Dismiss (Dkt. 37) at
3–8.
67 Lyondell Chem., 970 A.2d at 242 (quotation marks and citation omitted).
68 Malpiede, 780 A.2d at 1084.
69 QVC, 637 A.2d at 44.
70 See Strine, supra note 55, at 245 (“[O]ne of the most important consequences of the
Delaware [public benefit corporation] statute is that it makes clear that the Revlon doctrine
does not apply to benefit corporations. Under Revlon in the traditional public company
context, a board of directors that has decided to sell the corporation in a change of control
transaction must, within the discretion afforded it by positive regulatory law, sell the
corporation to the bidder offering to pay the highest price to the company’s stockholders.
Because of that, when Revlon applies, a board cannot consider which bidder is likely to be
the most responsible steward of the company’s assets in terms of operating them in a manner
that is in the best interests of the company’s employees, customers, communities, the
environment, or society generally. Dollars for stockholders is the only end that may be
considered, assuming positive law provides no other barrier.”) (citations omitted). But see
Frederick H. Alexander et al., M&A Under Delaware’s Public Benefit Corporation Statute: A
Hypothetical Tour, 4 HARV. BUS. L. REV. 255, 271 (2014) (“It is possible that courts might
continue to apply the heightened Revlon standard with respect to the total value achieved in
a change of control transaction. Under this approach, even though the deferential 365(b)
standard would apply to allocating and balancing value among the stockholders and public
beneficiaries, a court might apply a reasonableness standard to the total value maximizing
process.”); id. at 270 (“We expect, however, that these [Revlon] precepts would operate
differently in the case of a [public benefit corporation].”).
15
Plaintiffs recognize that MPower’s status as a public benefit corporation would
require the Court to apply some “modified” version of Revlon. 71
Plaintiffs argue that there is still room for Revlon to apply in the public benefit
corporation context. 72 Construing Revlon as a standard of review, that is possible.
The “enormous implications” 73 inherent in a change-of-control transaction do not
vanish simply because a corporation is a public benefit corporation. To avoid
confusion, one might refer to this type of application of enhanced scrutiny as “PBC”
enhanced scrutiny, rather than Revlon.
Such an application of enhanced scrutiny to the decisions of directors of public
benefit corporations might examine whether the directors’ actions in balancing the
interests required under Section 365(a) fell outside the range of reasonableness. As
explained below, however, I need not reach this question because Plaintiffs have
failed to plead facts sufficient to rebut the safe harbor in Section 365(b). 74
71 See Pls. AB at 19 (“Of course, the Court’s commentary on the unwavering obligation
to act solely for the benefit of stockholders could be modified here due to MPower’s status as
a public benefit corporation[.]”).
72 Pls. AB at 12–15.
73 El Paso, 41 A.3d at 439.
74 Even if I were to reach the enhanced scrutiny analysis, I would almost certainly
conclude that Plaintiffs have not pled facts that would support a reasonable inference that
the Special Committee acted unreasonably in balancing the interests in Section 365(a).
Indeed, Plaintiffs do not even attempt to plead as much. Instead, Plaintiffs make the
conclusory argument—for the first time in their answering brief—that no balancing occurred.
Plaintiffs base this conclusion on the lack of any record that the Special Committee engaged
in any balancing. This is an improper attempt by Plaintiffs to reallocate their pleading stage
burden to Defendants. See Malpiede, 780 A.2d at 1084 (“Although the Revlon doctrine
imposes enhanced judicial scrutiny of certain transactions involving a sale of control, it does
not eliminate the requirement that plaintiffs plead sufficient facts to support the underlying
claims for a breach of fiduciary duties in conducting the sale.”). Additionally, Plaintiffs’
16
3. Section 365(b)’s Safe Harbor
Defendants moved to dismiss Plaintiffs’ breach of fiduciary duty claim under
Section 365(b) of the DGCL. Section 365(b) is a statutory safe harbor for directors of
public benefit corporations. That section provides, in relevant part:
[W]ith respect to a decision implicating the balance requirement in
subsection (a) of this section, [a director of a public benefit corporation]
will be deemed to satisfy such director’s fiduciary duties to stockholders
and the corporation if such director’s decision is both informed and
disinterested and not such that no person of ordinary, sound judgment
would approve. 75
Plaintiffs bear the burden of pleading facts supporting a reasonable inference that
the requirements of the safe harbor were not satisfied. 76 Plaintiffs have failed to do
so here.
a. Informed and Disinterested
Plaintiffs concede that the Special Committee members were disinterested and
independent. 77 The question then becomes whether the Special Committee was
assertion that they do not have the record to plead a lack of balancing rings hollow, given
Plaintiffs’ failure to seek books and records under 8 Del. C. § 220. See Thermopylae Cap. P’rs,
L.P. v. Simbol, Inc., 2016 WL 368170, at *17 (Del. Ch. Jan. 29, 2016) (“Plaintiff could have
obtained pertinent facts through an action under Section 220, instead of suggesting that the
Court speculate as to the existence of a claim.”).
75 8 Del. C. § 365(b).
76 Ayers v. Foley, --- A.3d ---, 2026 WL 1723538, at *14 n.168 (addressing a different
safe harbor statute and explaining: “[t]he plaintiff bears the burden of pleading facts
supporting a reasonable inference that Section 144’s statutory requirements were not
satisfied.”).
77 See MTE Transcript at 34; MTD Transcript at 48:9–23.
17
“informed.” This is an undefined term in the statute, 78 so it “must be given [its]
ordinary, common meaning.” 79
Under Delaware corporation law, “directors have a fiduciary obligation to
‘inform themselves, prior to making a business decision, of all material information
reasonably available to them.’” 80 “A director’s duty to exercise an informed business
judgment implicates the duty of care.” 81 “For purposes of the standard of conduct,
the duty of care requires that directors exercise reasonable care.” 82
For purposes of the standard of review, the level of care varies:
• When the business judgment rule applies, the level of carelessness is
gross negligence.
78 Section 365(a)’s use of the undefined term “informed” can be juxtaposed with the
language employed in Section 144(a)(1)’s safe harbor. Under Section 144(a)(1), the approval
of disinterested directors can act as a safe harbor for director- or officer-conflicted
transactions if “[t]he material facts as to the director’s or officer’s relationship or interest and
as to the act or transaction, including any involvement in the initiation, negotiation, or
approval of the act or transaction, are disclosed or are known to all members of the board of
directors or a committee of the board of directors[.]” 8 Del. C. § 144(a)(1). Section 144(a)(1)
goes on to require that the disinterested directors’ approval of the act or transaction be “in
good faith and without gross negligence[.]” Id. In other words, Section 144(a)(1) supplies the
information that must be disclosed to or known by the decision-making directors, and it
provides the standard of review (business judgment) by requiring that the approval be “in
good faith and without gross negligence.” See YWCA, 356 A.3d at 490 (explaining that gross
negligence is required to plead a breach of the duty of care where the business judgment rule
applies). By contrast, Section 365(a) requires that directors be “informed” in their decision-
making to satisfy the safe harbor, but does not provide the information that must be known
by or disclosed to the directors or the standard of review that would apply to the Court’s
analysis of that requirement.
79 Oceanport Indus., Inc. v. Wilm. Stevedores, Inc., 636 A.2d 892, 900 (Del. 1994); see
also Kofron v. Amoco Chems. Corp., 441 A.2d 226, 230 (Del. 1982) (“When this Court is faced
with a novel question of statutory construction, . . . we give the statutory words their
commonly understood meanings.”).
80 Aronson v. Lewis, 473 A.2d 805, 812 (Del. 1984) (subsequent history omitted).
81 McMullin v. Beran, 765 A.2d 910, 921 (Del. 2000).
82 YWCA, 356 A.3d at 490 (citing Aronson, 473 A.2d at 812).
18
• When enhanced scrutiny applies, the level of carelessness is action
that falls outside the range of reasonableness.
• When entire fairness applies, the level of carelessness is action
resulting in a decisionmaking process that fails to satisfy the fair
dealing dimension of the unitary entire fairness test. 83
This begs the question of whether enhanced scrutiny applies to the Court’s evaluation
of the safe harbor’s “informed” requirement where a change-of-control transaction is
challenged.
Some might argue that enhanced scrutiny applies to the Court’s analysis of the
“informed” requirement because one “of the established situations in which enhanced
scrutiny applies [is] present,” 84 i.e., a change-of-control transaction. 85 Others may
83 Id. (citations omitted).
84 In re McDonald’s Corp. S’holder Deriv. Litig., 291 A.3d 652, 686 (Del. Ch. 2023)
(“The analysis starts with the default standard of the business judgment rule. None of the
established situations in which enhanced scrutiny applies are present in this case, rendering
that standard inapplicable.”); see also In re Rural Metro Corp., 88 A.3d 54, 84 (Del. Ch. 2014)
(“In this case, the Board approved a sale of Rural to Warburg for cash. This transactional
context causes the standard of review to intensify from the business judgment rule to
enhanced scrutiny.”); YWCA, 356 A.3d at 488–89 (“Enhanced scrutiny applies to specific,
recurring, and readily identifiable situations marked by two features. First, there is a
distinct decision-making context where the realities of the situation can subtly undermine
the decisions of even independent and disinterested fiduciaries. Second, the decision under
review involves the directors intruding into a space where stockholders possess rights of their
own. The directors’ exercise of corporate power therefore raises questions about the
allocations of authority within the entity and, from a theoretical perspective, implicates the
principal-agent problem. The resulting scenarios call for an intermediate standard of review
that examines ‘the reasonableness of the end that the directors chose to pursue, the path that
they took to get there, and the fit between the means and the end.’”).
85 See Flannery v. Genomic Health, Inc., 2021 WL 3615540, at *12 (Del. Ch. Aug. 16,
2021) (“Delaware courts will move past the business judgment rule and review director
conduct with enhanced scrutiny under Revlon when directors are confronted with a change
of control transaction that presents the board with the opportunity to secure ‘the best value
reasonably available to the stockholders.’”) (quoting QVC, 637 A.2d at 43); Barkan, 567 A.2d
at 1286 (“We believe that the general principles announced in Revlon, Unocal [], and